Displaying items by tag: school of medicine

A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.

Colleagues explain say retiring Animal Resources Program Director Samuel Cartner, DVM, Ph.D., has helped shape the institution’s research.

Benjamin Larimer, Ph.D., has received a five-year, $1.5-million New Innovator Award grant to develop a PET imaging test that identifies patients most likely to benefit from immunotherapy.

Using extensive testing, diagnosis and clinical data from across the Deep South, this project will be the first to analyze multiple dimensions of inequality to clarify contributions to COVID-19 disparities.

ScopeAssist, invented by a physician and an engineer, is designed to help surgeons deal with the rigors associated with endoscopic surgeries.

Doctors don’t have anything to reliably collect urine from neonates. A solution to this problem earned a commercialization grant from the U.S. Economic Development Administration.

You, your co-workers and your family all benefit if you are participate in UAB’s randomized sentinel testing — and this simple, self-administered swab doesn’t take a test away from anyone else.

Can essential oils diffuse the coronavirus? What about keto diets? If UV rays kill viruses, should I wear sunblock? UAB’s Molly Fleece, M.D., is tackling common COVID-19 searches to counteract rampant misinformation online.

Most PPE goes on the provider, not the patient. A solution to this problem from UAB faculty earned them a commercialization grant from the U.S. Economic Development Administration.

An interdisciplinary team of faculty and graduate students are using machine learning to identify geographic areas in which social determinants contribute to the COVID-19 burden as a way to improve the public health response.

The immune system’s first responders are implicated in acute respiratory distress syndrome, which greatly increases mortality in patients with COVID-19. With pilot funding from UAB’s urgent COVID-19 research initiative, investigators are exploring a potentially powerful new form of treatment.

Ten graduate faculty were honored with the UAB Graduate Dean’s Excellence in Mentorship Award during a virtual reception Sept. 9. See what the award recipients say they learned from UAB’s up-and-coming scientists.

Moon Nahm, M.D., has identified the crucial antibodies for pneumococcal vaccines and helped lower prices from $100 per dose to $2. With pilot funding from UAB’s urgent COVID-19 research initiative, Nahm is adapting his proven techniques to SARS-CoV-2.

Alabamians have early access to potentially life-saving vaccines and treatments for COVID-19 through UAB. Why? The same reasons that clinical trials activity at UAB has more than doubled in the past five years. Here's how it happened.

A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.

UAB is enrolling patients as part of randomized controlled trials that experts say are necessary to prove the efficacy of the much-discussed COVID-19 treatment.

Twelve faculty have been selected to receive the President’s Award for Excellence in Teaching, which honors those who have demonstrated exceptional accomplishments in teaching. The 2020 honorees represent each school, the College of Arts and Sciences, the Honors College and the Graduate School.

In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.

Advice on mental and emotional well-being from UAB leadership and professional development expert Michael Wiederman, Ph.D.

With a nearly $3 million grant from the NIH, researchers are studying interactions among sleep, nicotine and race.

Many people are looking to antibody tests for peace of mind. But the results aren’t actionable at this point, an infectious diseases expert says. Learn more about UAB’s current and future antibody testing efforts.

Project LEAP will make novel use of integrated patient navigation and student champions to help high-risk young residents.

Pathology department leaders explain pooled testing and other innovations behind the largest higher-education testing initiative in the nation.

Neurologist Peter King, M.D., shares his experience coming to terms with telehealth.

Gene Siegal, M.D., Ph.D., interim chair of Genetics and executive vice chair of Pathology, is one of 20 named Fellows of the scientific research honor society for his distinguished contributions as a physician scientist, scholar and leader in academic medicine.

Page 1 of 7